Last Updated November 2026
What Is Ozempic®? Indications, Mechanism, and Clinical Facts
Ozempic® is a prescription-only injectable medication manufactured by Novo Nordisk that gained significant public attention as part of the broader conversation surrounding GLP-1 receptor agonists. While frequently mentioned alongside weight management discussions, Ozempic® was developed and approved specifically for glycemic management and cardiovascular risk reduction.
What Is Ozempic® FDA-Approved For?
The U.S. Food and Drug Administration (FDA) approved Ozempic® for specific medical indications in adults:
- Glycemic Control: As an adjunct to diet and exercise to improve blood sugar (glucose) and HbA1c levels in adults with type 2 diabetes mellitus.
- Cardiovascular Risk Reduction: To reduce the risk of major adverse cardiovascular events (such as cardiovascular death, non-fatal heart attack, or stroke) in adults with type 2 diabetes and established cardiovascular disease.
- Kidney Protection: To reduce the risk of sustained kidney function decline and end-stage kidney disease in adults with type 2 diabetes and chronic kidney disease.
(Note: While weight reduction is a well-documented secondary effect in clinical trials, Ozempic® is not FDA-approved as a standalone weight-loss medication. Its sister brand, Wegovy®, contains the same active molecule—semaglutide—at a higher maximum maintenance dose and is specifically FDA-approved for chronic weight management).
How Does Ozempic® Work?
The active ingredient in Ozempic® is semaglutide, a synthetic peptide that mimics native glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the gut in response to food intake. It functions across three main physiological pathways:
- Glucose-Dependent Insulin Release: It stimulates the pancreas to secrete insulin when blood sugar levels rise, helping move glucose into cells.
- Glucagon Suppression: It prevents the liver from releasing excess stored glucose into the bloodstream.
- Delayed Gastric Emptying: It slows down the rate at which food exits the stomach, which promotes prolonged satiety and helps prevent sharp post-meal blood sugar spikes.
Ozempic® is administered once weekly via a subcutaneous injection in the abdomen, thigh, or upper arm.
Common Side Effects and Important Safety Precautions
The most frequently reported side effects are gastrointestinal and typically occur during initial dose titration:
- Nausea and vomiting
- Diarrhea or constipation
- Abdominal discomfort and acid reflux
- Fatigue
Boxed Warning & Contraindications: Ozempic® carries an FDA boxed warning regarding the risk of thyroid C-cell tumors. It is strictly contraindicated in individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and during pregnancy. Clinical screening is also required for patients with a history of pancreatitis, gallbladder disease, or diabetic retinopathy.
Comprehensive Medical Oversight with Dr. Fortino
Medications affecting metabolic pathways require thorough diagnostic evaluation and ongoing physician supervision:
- Board-Certified Clinical Care: Dr. Robert Fortino brings nearly 30 years of medical experience evaluating metabolic health and clinical weight therapies.
- In-Person Diagnostic Evaluation: Every patient undergoes a comprehensive in-person medical evaluation, baseline metabolic lab panel, and health history assessment at our South Philadelphia or Turnersville, NJ offices to determine the appropriate, safe treatment pathway.
- Local Excellence: Voted the 2026 Philly Favorites Gold Winner for Weight Loss Center by readers of The Philadelphia Inquirer.
Schedule a Consultation:
- South Philadelphia Office: 1822 S. Broad Street, Philadelphia, PA 19145 | (215) 336-8000
- Turnersville / South Jersey Office: 129 Johnson Road, Suite A3, Turnersville, NJ 08012 | (856) 318-4100
Disclaimer: Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Dr. Robert Fortino and this medical practice are independent healthcare entities with no corporate affiliation, endorsement, or sponsorship from Novo Nordisk A/S. Reference to commercial brand names is strictly for informational and educational identification. Prescriptions are provided solely at the physician’s medical discretion following a formal diagnostic evaluation. Compounded medications, where clinically indicated for individualized patient care, are prepared by licensed compounding pharmacies and are not FDA-approved drugs or generic equivalents.